Soo‐Yeon Hwang

497 total citations
22 papers, 374 citations indexed

About

Soo‐Yeon Hwang is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Soo‐Yeon Hwang has authored 22 papers receiving a total of 374 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 9 papers in Oncology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Soo‐Yeon Hwang's work include Cancer therapeutics and mechanisms (8 papers), Bioactive Compounds and Antitumor Agents (4 papers) and Heat shock proteins research (4 papers). Soo‐Yeon Hwang is often cited by papers focused on Cancer therapeutics and mechanisms (8 papers), Bioactive Compounds and Antitumor Agents (4 papers) and Heat shock proteins research (4 papers). Soo‐Yeon Hwang collaborates with scholars based in South Korea, Japan and United States. Soo‐Yeon Hwang's co-authors include Youngjoo Kwon, Seojeong Park, Younghwa Na, Yun‐Sil Lee, Hyunji Jo, Eung-Seok Lee, Aarajana Shrestha, Hyojin Park, Tara Man Kadayat and Seung Bae Rho and has published in prestigious journals such as Nature Communications, Chemical Communications and International Journal of Molecular Sciences.

In The Last Decade

Soo‐Yeon Hwang

21 papers receiving 373 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Soo‐Yeon Hwang South Korea 10 220 115 66 65 57 22 374
Tiantao Gao China 12 297 1.4× 96 0.8× 48 0.7× 35 0.5× 55 1.0× 18 460
Yongping Cui China 5 228 1.0× 99 0.9× 56 0.8× 41 0.6× 40 0.7× 10 437
Elin Lindhagen Sweden 14 245 1.1× 138 1.2× 67 1.0× 35 0.5× 50 0.9× 28 505
Christy W.S. Tong Hong Kong 6 287 1.3× 162 1.4× 147 2.2× 92 1.4× 61 1.1× 7 530
Seojeong Park South Korea 14 318 1.4× 165 1.4× 54 0.8× 59 0.9× 178 3.1× 33 578
S. Neslihan Alpay United States 6 308 1.4× 70 0.6× 84 1.3× 41 0.6× 37 0.6× 7 438
Cristina Andreani Italy 12 330 1.5× 126 1.1× 99 1.5× 53 0.8× 27 0.5× 20 494
Somsundaram Chettiar United States 12 283 1.3× 161 1.4× 64 1.0× 61 0.9× 124 2.2× 16 521
Caterina Bartolacci Italy 11 224 1.0× 78 0.7× 77 1.2× 48 0.7× 25 0.4× 15 345
Chee Onn Leong Malaysia 5 236 1.1× 105 0.9× 90 1.4× 46 0.7× 56 1.0× 8 416

Countries citing papers authored by Soo‐Yeon Hwang

Since Specialization
Citations

This map shows the geographic impact of Soo‐Yeon Hwang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Soo‐Yeon Hwang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Soo‐Yeon Hwang more than expected).

Fields of papers citing papers by Soo‐Yeon Hwang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Soo‐Yeon Hwang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Soo‐Yeon Hwang. The network helps show where Soo‐Yeon Hwang may publish in the future.

Co-authorship network of co-authors of Soo‐Yeon Hwang

This figure shows the co-authorship network connecting the top 25 collaborators of Soo‐Yeon Hwang. A scholar is included among the top collaborators of Soo‐Yeon Hwang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Soo‐Yeon Hwang. Soo‐Yeon Hwang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lee, Jin Woo, Kyung-Ah Lee, In-Hwan Jang, et al.. (2025). Microbiome-emitted scents activate olfactory neuron-independent airway-gut-brain axis to promote host growth in Drosophila. Nature Communications. 16(1). 2199–2199. 1 indexed citations
3.
Hwang, Soo‐Yeon, Seojeong Park, Yi Liu, et al.. (2025). Targeting the HER2-ELF3-KRAS axis: a novel therapeutic strategy for KRASG13D colorectal cancer. Molecular Cancer. 24(1). 139–139. 1 indexed citations
5.
Hwang, Soo‐Yeon, Seojeong Park, Hyunji Jo, et al.. (2022). Interrupting specific hydrogen bonds between ELF3 and MED23 as an alternative drug resistance-free strategy for HER2-overexpressing cancers. Journal of Advanced Research. 47. 173–187. 7 indexed citations
6.
Hwang, Soo‐Yeon, et al.. (2022). Topoisomerase IIα inhibitory and antiproliferative activity of dihydroxylated 2,6-diphenyl-4-fluorophenylpyridines: Design, synthesis, and structure-activity relationships. Bioorganic & Medicinal Chemistry Letters. 60. 128606–128606. 3 indexed citations
7.
Choi, Seul-Ki, Soo‐Yeon Hwang, Joohyun Lee, et al.. (2022). Design, synthesis, and biological evaluation of novel HSP27 inhibitors to sensitize lung cancer cells to clinically available anticancer agents. Bioorganic Chemistry. 130. 106260–106260. 6 indexed citations
8.
Park, Seojeong, Jae‐Ho Shin, Soo‐Yeon Hwang, et al.. (2022). Synthesis and evaluation of 7-(3-aminopropyloxy)-substituted flavone analogue as a topoisomerase IIα catalytic inhibitor and its sensitizing effect to enzalutamide in castration-resistant prostate cancer cells. European Journal of Medicinal Chemistry. 246. 114999–114999. 6 indexed citations
9.
Hwang, Soo‐Yeon, et al.. (2022). Hypoxia‐induced ELF3 promotes tumor angiogenesis through IGF1/IGF1R. EMBO Reports. 23(8). e52977–e52977. 29 indexed citations
10.
Hwang, Soo‐Yeon, Jae Ho Shin, Younghwa Na, et al.. (2021). Drug-Like Small Molecule HSP27 Functional Inhibitor Sensitizes Lung Cancer Cells to Gefitinib or Cisplatin by Inducing Altered Cross-Linked Hsp27 Dimers. Pharmaceutics. 13(5). 630–630. 7 indexed citations
11.
Hwang, Soo‐Yeon, Aarajana Shrestha, Seojeong Park, et al.. (2021). Identification of new halogen-containing 2,4-diphenyl indenopyridin-5-one derivative as a boosting agent for the anticancer responses of clinically available topoisomerase inhibitors. European Journal of Medicinal Chemistry. 227. 113916–113916. 10 indexed citations
12.
Hwang, Soo‐Yeon, Seojeong Park, Daeun Kim, et al.. (2021). Discovery of a 2,4-diphenyl-5,6-dihydrobenzo(h)quinolin-8-amine derivative as a novel DNA intercalating topoisomerase IIα poison. European Journal of Medicinal Chemistry. 226. 113860–113860. 8 indexed citations
13.
You, Young‐Ah, Soo‐Yeon Hwang, Soo-Min Kim, et al.. (2021). Identification of Indicators for Preterm Birth Using Retinoid Metabolites. Metabolites. 11(7). 443–443. 8 indexed citations
15.
Kim, Mi Jeong, Soo‐Yeon Hwang, Youngjoo Kwon, et al.. (2020). Plumbagin Suppresses Pulmonary Fibrosis via Inhibition of p300 Histone Acetyltransferase Activity. Journal of Medicinal Food. 23(6). 633–640. 16 indexed citations
16.
Hwang, Soo‐Yeon, Hyunji Jo, Jae Ho Shin, et al.. (2020). Specific Roles of HSP27 S15 Phosphorylation Augmenting the Nuclear Function of HER2 to Promote Trastuzumab Resistance. Cancers. 12(6). 1540–1540. 22 indexed citations
17.
Hwang, Soo‐Yeon, Soo‐Yeon Park, Jung Yeon Hong, et al.. (2020). Field-based rational design of p300 histone acetyltransferase inhibitor and systematic evaluation as an anti-fibrotic agent. Chemical Communications. 56(68). 9795–9798. 10 indexed citations
18.
Hwang, Soo‐Yeon, Seojeong Park, & Youngjoo Kwon. (2019). Recent therapeutic trends and promising targets in triple negative breast cancer. Pharmacology & Therapeutics. 199. 30–57. 181 indexed citations
19.
Park, Seojeong, Soo‐Yeon Hwang, Jae‐Ho Shin, et al.. (2019). A chromenone analog as an ATP-competitive, DNA non-intercalative topoisomerase II catalytic inhibitor with preferences toward the alpha isoform. Chemical Communications. 55(85). 12857–12860. 13 indexed citations
20.
Hwang, Soo‐Yeon, et al.. (2017). Synthesis and biological effect of chrom-4-one derivatives as functional inhibitors of heat shock protein 27. European Journal of Medicinal Chemistry. 139. 892–900. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026